What is TB-500?
TB-500 is a synthetic analogue of Thymosin Beta-4 (Tβ4), a small, naturally occurring protein found in virtually all human and animal cells. Thymosin Beta-4 plays a fundamental role in actin polymerization — the process by which cells build their internal scaffolding — and is released in large quantities at sites of injury.
TB-500 represents the active fragment of Thymosin Beta-4 (amino acids 17–23) believed to be responsible for most of its healing and anti-inflammatory effects.
How TB-500 Works
- Actin regulation: Binds to G-actin, sequestering it and influencing cell migration and proliferation
- Cell migration: Facilitates the movement of repair cells (stem cells, keratinocytes) to injury sites
- Angiogenesis: Promotes new blood vessel formation critical for tissue repair
- Anti-inflammation: Downregulates pro-inflammatory cytokines
- Extracellular matrix remodeling: Influences collagen deposition and tissue architecture
Research Summary
Musculoskeletal Healing
Animal models show TB-500 accelerates healing of muscle tears, tendon injuries, and ligament damage. Its ability to promote stem cell migration makes it particularly interesting for regenerative applications.
Cardiac Repair
Several studies in rodent cardiac infarction models found that systemic TB-500 reduced infarct size, improved cardiac function, and stimulated angiogenesis in damaged heart tissue — suggesting potential cardiovascular applications.
Hair Regrowth
Some early research suggests Thymosin Beta-4 plays a role in hair follicle activation, with TB-500 potentially stimulating dormant follicles.
Safety & Regulatory Considerations
- No published human clinical trials for TB-500 specifically
- Parent compound (Thymosin Beta-4) has been investigated in human wound healing trials with good tolerability
- WADA Prohibition: TB-500 is explicitly prohibited in competitive athletics as a peptide hormone/growth factor
- FDA has restricted its use in compounding pharmacies
Medical Disclaimer: TB-500 is not approved for human use. This content is for educational and research purposes only. Do not use this compound without proper medical supervision.
Related Reading
- TB-500 (Thymosin Beta-4): Research and Evidence Guide — Full breakdown of TB-500’s healing mechanisms, animal research, and human evidence gaps
- The Science Behind BPC-157 and Injury Recovery — Compare TB-500 with BPC-157 for injury recovery applications
- Peptide Combination Therapy: Evidence and Principles — The BPC-157 + TB-500 stack: rationale and protocol considerations
- Peptides in Sport and Bodybuilding: Risks and Realities — WADA prohibition context and risks of recovery peptide use in athletic contexts
- FDA Peptide Status 2026: What’s Legal, What’s Not — TB-500’s compounding restriction status
Safety Profile Summary
TB-500 appears well-tolerated in animal studies. Limited human safety data exists. It is prohibited in competitive sports by WADA as a peptide hormone.
References & Further Reading
- 1. Goldstein AL, Hannappel E, Kleinman HK. Thymosin Beta4: Actin-Sequestering Protein Moonlights to Repair Injured Tissues. Trends Mol Med. 2005;11(9):421-9. [PubMed ↗]
- 2. Bao W, et al. Cardioprotection by Systemic Dosing of Thymosin Beta Four Following Ischemic Myocardial Injury. Front Pharmacol. 2013;4:149. [PubMed ↗]
- 3. Bock-Marquette I, et al. Thymosin Beta4 Activates Integrin-Linked Kinase and Promotes Cardiac Cell Migration, Survival and Cardiac Repair. Nature. 2004;432(7016):466-72. [PubMed ↗]
- 4. Huff T, et al. Beta-Thymosins, Small Acidic Peptides with Multiple Functions. Int J Biochem Cell Biol. 2001;33(3):205-20. [PubMed ↗]
- 5. ClinicalTrials.gov — Studies on Thymosin Beta-4. [ClinicalTrials.gov ↗]